Overview

Pharmacokinetics in Oral and Intranasal Formulations of Zolmitriptan.

Status:
Completed
Trial end date:
2023-09-29
Target enrollment:
Participant gender:
Summary
This is a phase I study to evaluate the PBPK of zolmitriptan intranasal versus oral administration.
Phase:
Phase 1
Details
Lead Sponsor:
Parc de Salut Mar
Collaborator:
Food and Drug Administration (FDA)
Treatments:
Oxazolidinones
Zolmitriptan